HBA adds 10 to its board.

Share this article:
The Healthcare Businesswomen's Association (HBA) has appointed an additional 10 new members to its 25-member advisory board. Many of the new members are recipients of the HBA's annual Woman of the Year or Honorable Mentor awards.
HBA president Daria Blackwell said in a statement, "The association's advisory board works with its board of directors to address the status of women in the healthcare industry and provides strategic direction on ways the association can further the advancement of women's careers through the HBA's national and regional initiatives."
Barbara Pritchard, president-elect of the HBA, added that "because these advisory board members have seen many changes in the industry, they are in an excellent position to play an important role as mentors in the HBA's development as an organization."
New HBA advisory board members, all of whom will serve a three-year term, are: Carol Ammon, chairman and chief executive, Endo Pharmaceuticals; Judith Britz, Ph.D., chairman and chief executive, Cylex; Annie Callanan, executive vice president, Advanstar Medical Economics Healthcare Publishing Group; Teri Cox, senior managing partner, Cox Communications Partners; Ronald Dollens, president and chief executive, Guidant Corp.; James Hynd, senior vice president, commercial operations, Solvay Pharmaceuticals; Candice Lange, director, Workforce Partnering Eli Lilly; Jill Mueller, group vice president, human resources pharmaceuticals group and global pharmaceutical R&D, Abbott Laboratories; Christine Poon, worldwide chairman, medicines and nutritionals, Johnson & Johnson, and Rowena Track, vice president, global e-business, global strategic marketing, Bayer HealthCare.
Share this article:
close

Next Article in News

Email Newsletters

More in News

House bill would speed approval once EU OKs same product

House bill would speed approval once EU OKs ...

The Speeding Access to Already Approved Pharmaceuticals Act of 2014 would require FDA to expedite the review of pharmaceuticals that are already approved by the European Union

Rep access continues to shrink

Rep access continues to shrink

Sales reps are experiencing even more limited physician access, according to a report by Chicago consultancy ZS Associates.

Allergan touts reorg, plans to lay off 13% of workforce

Allergan touts reorg, plans to lay off 13% ...

Allergan's second-quarter earnings, and a new round of cuts, are now part of the Botox maker's record as it seeks to remain independent.